Medical Care Technologies (OTC PINK:MDCE) Launches Next-Generation AI Validation Program Targeting Clinical-Grade Accuracy
Medical Care Technologies (OTC PINK:MDCE) on October 6, 2025 said it will benchmark an upcoming AI diagnostic model against the HAM10000 public dermatology dataset to validate its image recognition architecture for detecting multiple skin lesion types.
The company said the HAM10000 data will be used under a research license to assess model precision, sensitivity, and specificity relative to peer‑reviewed standards as part of an ongoing proof‑of‑concept development. Management framed this as aligning performance metrics with academic standards and noted risks including data variability, integration challenges, and evolving regulatory guidance.
Medical Care Technologies (OTC PINK:MDCE) il 6 ottobre 2025 ha detto che confronterà un imminente modello diagnostico basato su AI con il dataset pubblico di dermatologia HAM10000 per convalidare la sua architettura di riconoscimento delle immagini per rilevare molteplici tipi di lesioni cutanee.
L'azienda ha detto che i dati HAM10000 verranno utilizzati sotto una licenza di ricerca per valutare la precisione, la sensibilità e la specificità del modello rispetto agli standard tra peer (peer‑reviewed) come parte di uno sviluppo concettuale in corso. La dirigenza ha inquadrato questo come un allineamento delle metriche di performance agli standard accademici e ha osservato rischi tra cui variabilità dei dati, sfide di integrazione e l'evoluzione delle linee guida normative.
Medical Care Technologies (OTC PINK:MDCE) anunció el 6 de octubre de 2025 que comparará un próximo modelo diagnóstico de IA con el conjunto de datos público HAM10000 de dermatología para validar su arquitectura de reconocimiento de imágenes para detectar múltiples tipos de lesiones cutáneas.
La empresa dijo que los datos HAM10000 se utilizarán bajo una licencia de investigación para evaluar la precisión, la sensibilidad y la especificidad del modelo en relación con estándares revisados por pares como parte de un desarrollo de prueba de concepto en curso. La gerencia enmarcó esto como alinear las métricas de rendimiento con estándares académicos y señaló riesgos que incluyen variabilidad de datos, desafíos de integración y la evolución de las directrices regulatorias.
Medical Care Technologies (OTC PINK:MDCE)가 2025년 10월 6일에 곧 출시될 AI 진단 모델을 HAM10000 공용 피부과 데이터셋과 벤치마킹하여 다중 피부 병변 유형 감지를 위한 이미지 인식 아키텍처를 검증한다고 밝혔다.
회사는 HAM10000 데이터가 연구 라이선스 하에 모델의 정밀도, 민감도 및 특이도를 동료 검토 기준에 따라 평가하는 데 사용될 예정이라고 말했다. 이는 진행 중인 개념 증명 개발의 일부로서 학계 표준과의 성능 지표 정렬로 설명되었으며, 데이터 변동성, 통합 과제, 변화하는 규제 지침 등 위험을 지적했다.
Medical Care Technologies (OTC PINK:MDCE) a annoncé le 6 octobre 2025 qu'il benchmarkerait un prochain modèle diagnostique basé sur l'IA avec le jeu de données HAM10000 public de dermatologie pour valider son architecture de reconnaissance d'images détectant plusieurs types de lésions cutanées.
L'entreprise a indiqué que les données HAM10000 seront utilisées dans le cadre d'une licence de recherche pour évaluer la précision, la sensibilité et la spécificité du modèle par rapport aux normes revues par les pairs dans le cadre d'un développement proof-of-concept en cours. La direction a présenté cela comme un alignement des métriques de performance sur les standards académiques et a noté des risques tels que la variabilité des données, les défis d'intégration et l'évolution des directives réglementaires.
Medical Care Technologies (OTC PINK:MDCE) sagte am 6. Oktober 2025, dass es ein kommendes KI-Diagnosemodell mit dem öffentlichen Dermatologie-Datensatz HAM10000 benchmarken wird, um seine Bild-Erkennungsarchitektur zur Erkennung mehrerer Arten von Hautläsionen zu validieren.
Das Unternehmen sagte, dass die HAM10000-Daten unter einer Forschungslizenz verwendet werden, um die Genauigkeit, Sensitivität und Spezifität des Modells im Vergleich zu von Fachkollegen geprüften Standards im Rahmen einer laufenden Proof-of-Concept-Entwicklung zu bewerten. Die Geschäftsführung stellte dies als Angleichung der Leistungskennzahlen an akademische Standards dar und wies auf Risiken wie Datenvariabilität, Integrationsherausforderungen und sich entwickelnde regulatorische Leitlinien hin.
Medical Care Technologies (OTC PINK:MDCE) قالت في 6 أكتوبر 2025 إنها ستقارن نموذج تشخيصي قائم على الذكاء الاصطناعي القادم مع مجموعة HAM10000 العامة في علم الأمراض الجلدية للتحقق من بنية التعرف على الصور للكشف عن أنواع متعددة من آفات الجلد.
وقالت الشركة إن بيانات HAM10000 ستُستخدم بموجب ترخيص بحثي لتقييم دقة النموذج وحساسيته ونوعيته مقابل معايير تمت مراجعته من قبل الزملاء كجزء من تطوير إثبات المفهوم الجاري. وصفت الإدارة ذلك بأنه تواءم لأداء النمو مع المعايير الأكاديمية وأشارت إلى مخاطر مثل تقلبات البيانات وتحديات الدمج وتغير الإرشادات التنظيمية.
Medical Care Technologies (OTC PINK:MDCE) 于 2025年10月6日 表示，将以 HAM10000 公共皮肤科数据集为基准来评估即将推出的 AI 诊断模型，以验证其用于检测多种皮肤病变类型的图像识别架构。
公司表示，HAM10000 数据将在研究许可下用于评估模型的准确性、灵敏度和特异性，相对于同行评审标准，作为正在进行的概念验证开发的一部分。管理层将此描述为使性能指标与学术标准对齐，并指出数据变异、整合挑战和日益变化的监管指南等风险。
- None.
- None.
MESA, AZ / ACCESS Newswire / October 6, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) announced its plan to benchmark its upcoming AI diagnostic model against the HAM10000 public dermatology dataset to validate its image recognition architecture for detecting various skin lesion types.
The benchmarking process will help evaluate model precision, sensitivity, and specificity relative to peer-reviewed standards. The HAM10000 data will be used under its research license as part of MDCE's ongoing proof-of-concept development.
"We are aligning our performance metrics with globally recognized academic standards," said CEO Marshall Perkins III. "This proactive benchmarking approach underscores our focus on building credible, evidence-backed AI systems for healthcare."
Company Website: www.medicalcaretechnologies.com
Safe Harbor Statement:
Forward-looking statements in this communication reflect current expectations and involve risks that may cause actual results to differ. Factors include data variability, integration challenges, and evolving regulatory guidance. The company assumes no obligation to update such statements.
Contact:
Investor Relations
Medical Care Technologies Inc.
info@infiniteauctions.com
Website: www.mdcestock.com
SOURCE: Medical Care Technologies Inc. (OTC PINK:MDCE)
View the original press release on ACCESS Newswire
FAQ
What did MDCE announce on October 6, 2025 about its AI diagnostic model?
How will MDCE use the HAM10000 dataset for validation of MDCE stock (MDCE)?
What performance metrics will MDCE evaluate when testing its AI model?
Does the MDCE announcement include financial results or revenue impact?
What risks did MDCE cite about its AI benchmarking program?
